Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris

Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles

(2020) Humberto H. Lara et al.   ACS Applied Materials & Interfaces

In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak

(2020) Brittany O'Brien et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rezafungin In Vitro Activity against Contemporary Clinical Nordic Candida Isolates and Candida auris Determined by the EUCAST Reference Method

(2020) Marie Helleberg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates

(2020) Marhiah C. Montoya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose-Based Hydrogels for Wound Dressing Applications

(2020) Abhishek Gupta et al.   BIOMACROMOLECULES

Oxadiazolylthiazoles as novel and selective antifungal agents

(2020) Mohamed Hagras et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Pan-resistant Candida auris Isolates from the Outbreak in New York are Susceptible to Ibrexafungerp: A Glucan Synthase Inhibitor

(2020) Yan Chun Zhu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Colistin interacts synergistically with echinocandins against Candida auris

(2020) A.L. Bidaud et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A Cerberus‐Inspired Anti‐Infective Multicomponent Gatekeeper Hydrogel against Infections with the Emerging “Superbug” Yeast Candida auris

(2020) Dennis Kubiczek et al.   MACROMOLECULAR BIOSCIENCE

Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris

(2020) Siham Shaban et al.   Scientific Reports

Facile Route of Fabricating Long-Term Microbicidal Silver Nanoparticle Clusters against Shiga Toxin-Producing Escherichia coli O157:H7 and Candida auris

(2020) Sheeana Gangadoo et al.   Coatings

Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?

(2020) Raquel Sabino et al.   Microorganisms

Antifungal evaluation of traditional herbal monomers and their potential for inducing cell wall remodeling in Candida albicans and Candida auris

(2020) Juanjuan Liu et al.   BIOFOULING

Multidrug-resistant Candida auris: an epidemiological review

(2020) Arunaloke Chakrabarti et al.   Expert Review of Anti-Infective Therapy

Inactivation of the multi-drug resistant pathogen Candida auris using ultraviolet germicidal irradiation (UVGI)

(2020) Angela R. Lemons et al.   JOURNAL OF HOSPITAL INFECTION

Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds

(2020) Martin van Eijk et al.   MEDICAL MYCOLOGY

Essential Oil-Based Design and Development of Novel Anti-Candida Azoles Formulation

(2020) Rania Hamdy et al.   MOLECULES

Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol

(2020) Vartika Srivastava et al.   PLoS One

Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species

(2020) Hassan E. Eldesouky et al.   Scientific Reports

Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities

(2020) Hassan E. Eldesouky et al.   Scientific Reports

In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris

(2020) Fruzsina Nagy et al.   Frontiers in Microbiology

Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic Candida Species

(2020) Nicole M. Revie et al.   mSphere

Antifungal activity of gepinacin-scaffold GPI anchor biosynthesis inhibitors with improved metabolic stability

(2020) Sean D. Liston et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model

(2020) Laís Salomão Arias et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of Ibrexafungerp (SCY-078) Against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model

(2020) M Ghannoum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Manogepix (APX001A) in vitro activity against Candida auris. A head to head comparison of EUCAST and CLSI MICs.

(2020) Maiken Cavling Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris

(2020) Thayná Lopes Barreto et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris

(2020) Rodnei Dennis Rossoni et al.   Frontiers in Cellular and Infection Microbiology

Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro

(2020) Dennis Kubiczek et al.   Antibiotics-Basel

Bismuth Nanoantibiotics Display Anticandidal Activity and Disrupt the Biofilm and Cell Morphology of the Emergent Pathogenic Yeast Candida auris

(2020) Roberto Vazquez-Munoz et al.   Antibiotics-Basel

NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris

(2020) Levi G. Cleare et al.   Journal of Fungi

In Vitro Activity of Manogepix against Multidrug-Resistant and Panresistant Candida auris from the New York Outbreak

(2020) YanChun Zhu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potent synergistic interactions between lopinavir and azole antifungal drugs against emerging multidrug-resistant Candida auris

(2020) Hassan E. Eldesouky et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris

(2020) Hoang N. H. Tran et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Broad‐Spectrum Antifungal Agents: Fluorinated Aryl‐ and Heteroaryl‐Substituted Hydrazones

(2020) Nishad Thamban Chandrika et al.   ChemMedChem

Antifungal and anti‐biofilm effects of 6‐shogaol against Candida auris

(2020) H.‐R. Kim et al.   JOURNAL OF APPLIED MICROBIOLOGY

Herbicides That Target Acetohydroxyacid Synthase Are Potent Inhibitors of the Growth of Drug-Resistant Candida auris

(2020) Kylie A. Agnew-Francis et al.   ACS Infectious Diseases

α ‐Iodonitroalkenes as Potential Antifungal and Antitubercular Agents

(2020) Rambabu Pamarthi et al.   ChemistrySelect

Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections

(2020) Mahmoud Ghannoum et al.   Antibiotics-Basel

A second generation fungerp analog SCY-247, shows potent in vitro activity against Candida auris and other clinically relevant fungal isolates

(2020) Sherman Chu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A marine microbiome antifungal targets urgent-threat drug-resistant fungi

(2020) Fan Zhang et al.   SCIENCE

Novel 2-Aryloxazoline Compounds Exhibit an Inhibitory Effect on Candida spp., Including Antifungal-Resistant Isolates

(2020) Luis M. Z. Argomedo et al.   ACS Medicinal Chemistry Letters

An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris

(2020) Kali R. Iyer et al.   Nature Communications

In vitro synergy of isavuconazole in combination with colistin against Candida auris

(2020) Patrick Schwarz et al.   Scientific Reports

Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle–mediated trafficking

(2020) Miao Zhao et al.   JOURNAL OF CLINICAL INVESTIGATION

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

(2019) Michael A Pfaller et al.   Open Forum Infectious Diseases

Killing of Candida auris by UV-C: Importance of exposure time and distance

(2019) Theun de Groot et al.   MYCOSES

In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.

(2019) G. Tetz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance of Candida to azoles and echinocandins worldwide

(2019) K.E. Pristov et al.   CLINICAL MICROBIOLOGY AND INFECTION

Farnesol increases the activity of echinocandins against Candida auris biofilms

(2019) Fruzsina Nagy et al.   MEDICAL MYCOLOGY

Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris

(2019) Haroldo Cesar de Oliveira et al.   Frontiers in Cellular and Infection Microbiology

The efficacy of pulsed-xenon ultraviolet light technology on Candida auris

(2019) Caroline Maslo et al.   BMC INFECTIOUS DISEASES

In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris

(2019) Shivaprakash M Rudramurthy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Probiotics as antifungal agents: Experimental confirmation and future prospects

(2019) Janet Cheruiyot Kosgey et al.   JOURNAL OF MICROBIOLOGICAL METHODS

On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds

(2019) Arturo Casadevall et al.   mBio

Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen

(2019) Caroline Dal Mas et al.   Biomolecules

Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis

(2019) Nathan P. Wiederhold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae

(2019) Zoltán Tóth et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Candida auris outbreak: Mortality, interventions and cost of sustaining control

(2019) Surabhi K Taori et al.   JOURNAL OF INFECTION

In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species

(2019) Shahram Mahmoudi et al.   MYCOPATHOLOGIA

The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection

(2019) Shakti Singh et al.   PLoS Pathogens

In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism

(2019) A. L. Bidaud et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Sertraline as a promising antifungal agent: inhibition of growth and biofilm of Candida auris with special focus on the mechanism of action in vitro

(2019) M. Gowri et al.   JOURNAL OF APPLIED MICROBIOLOGY

A probiotic for candidiasis?

(2019) Ashley York   NATURE REVIEWS MICROBIOLOGY

Probiotic Yeasts Inhibit Virulence of Non-albicans Candida Species

(2019) Lohith Kunyeit et al.   mBio

Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal Activity

(2019) Fidel E. Morales Vicente et al.   ACS Omega

In Vitro Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B

(2019) Yongqin Wu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris

(2019) Nathan P. Wiederhold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents

(2019) Maiken Cavling Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Global epidemiology of emerging Candida auris

(2019) Johanna Rhodes et al.   CURRENT OPINION IN MICROBIOLOGY

Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics

(2019) Alan Talevi et al.   Expert Opinion on Drug Discovery

In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains

(2019) Francesco Orofino et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Distorted Gold(I)–Phosphine Complexes as Antifungal Agents

(2019) Emily K. Dennis et al.   JOURNAL OF MEDICINAL CHEMISTRY

Identification of a Phenylthiazole Small Molecule with Dual Antifungal and Antibiofilm Activity Against Candida albicans and Candida auris

(2019) Haroon Mohammad et al.   Scientific Reports

Potential of Gallium as an Antifungal Agent

(2019) Rafael Wesley Bastos et al.   Frontiers in Cellular and Infection Microbiology

Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species

(2018) Virginia Basso et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model

(2018) Miao Zhao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Significantly improved pharmacokinetics enhances in vivo efficacy of APX001 against echinocandin and multidrug resistant Candida isolates in a mouse model of invasive candidiasis

(2018) Yanan Zhao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris

(2018) Christopher L. Hager et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis

(2018) Nathan P. Wiederhold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris

(2018) Elizabeth L. Berkow et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Candida auris in contemporary mycology labs: A few practical tricks to identify it reliably according to one recent French experience

(2018) G. Desoubeaux et al.   JOURNAL DE MYCOLOGIE MEDICALE

The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis

(2018) E P Garvey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms

(2018) Marjan M Hashemi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model

(2018) Christopher L Hager et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice

(2018) Timothy J Break et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Surface disinfection challenges for Candida auris : an in-vitro study

(2018) R. Kean et al.   JOURNAL OF HOSPITAL INFECTION

The first isolate of Candida auris in China: clinical and biological aspects

(2018) Xiaojuan Wang et al.   Emerging Microbes & Infections

Pharmacodynamic Evaluation of Rezafungin (CD101) Against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model

(2018) Alexander J. Lepak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development

(2018) Gina Wall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

APX001A In Vitro Activity against Contemporary Blood Isolates and Candida auris Determined by the EUCAST Reference Method

(2018) Maiken Cavling Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris

(2018) Hassan E. Eldesouky et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Activity of novel antifungal compound APX001A against a large collection of Candida auris

(2018) Elizabeth L Berkow et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antifungal Activity of Octenidine Dihydrochloride and Ultraviolet-C light against Multidrug-Resistant Candida auris

(2018) Pretty Ponnachan et al.   JOURNAL OF HOSPITAL INFECTION

OUP accepted manuscript

(2018)   MEDICAL MYCOLOGY

A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion

(2018) Carlos Garcia et al.   Scientific Reports

The mycoparasitic yeast Saccharomycopsis schoenii predates and kills multi-drug resistant Candida auris

(2018) Klara Junker et al.   Scientific Reports

The Fungal Cyp51 Specific Inhibitor VT-1598 Demonstrates In vitro and In vivo Activity against Candida auris

(2018) Nathan P. Wiederhold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen

(2018) Jaroslava Dekkerová et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey

(2018) Nancy A Chow et al.   LANCET INFECTIOUS DISEASES

Drug repurposing: progress, challenges and recommendations

(2018) Sudeep Pushpakom et al.   NATURE REVIEWS DRUG DISCOVERY

Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species

(2018) José F. Muñoz et al.   Nature Communications

Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch

(2018) Huizhen Yue et al.   Emerging Microbes & Infections

Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens

(2018) Zeinab Mamouei et al.   mSphere

Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris

(2018) Alison M. Day et al.   mSphere

Drug development challenges and strategies to address emerging and resistant fungal pathogens

(2017) Matthew W. McCarthy et al.   Expert Review of Anti-Infective Therapy

Relative Resistance of the Emerging Fungal Pathogen Candida auris and Other Candida Species to Killing by Ultraviolet Light

(2017) Jennifer L. Cadnum et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Effectiveness of Disinfectants Against Candida auris and Other Candida Species

(2017) Jennifer L. Cadnum et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Candida auris : An emerging multidrug-resistant pathogen

(2017) David Sears et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus

(2017) Nathan P Wiederhold et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Nosocomial fungemia by Candida auris: First four reported cases in continental Europe

(2017) Alba Cecilia Ruiz Gaitán et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Investigation of the First Seven Reported Cases ofCandida auris,a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016

(2016) S. Vallabhaneni et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Emergence ofCandida auris: An International Call to Arms

(2016) Cornelius J. Clancy et al.   CLINICAL INFECTIOUS DISEASES

Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

(2016) Shawn R. Lockhart et al.   CLINICAL INFECTIOUS DISEASES

T-2307, a novel arylamidine, is transported intoCandida albicansby a high-affinity spermine and spermidine carrier regulated by Agp2

(2016) Hiroshi Nishikawa et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia

(2016) Belinda Calvo et al.   JOURNAL OF INFECTION

Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris

(2015) Sharanya Chatterjee et al.   BMC GENOMICS

Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae)

(2015) Carlos López-Abarrategui et al.   FASEB JOURNAL

The novel arylamidine T-2307 demonstratesin vitroandin vivoactivity against echinocandin-resistantCandida glabrata

(2015) Nathan P. Wiederhold et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis

(2015) Dharmendra Kumar et al.   Journal of Infection in Developing Countries

The Novel Arylamidine T-2307 MaintainsIn VitroandIn VivoActivity against Echinocandin-Resistant Candida albicans

(2014) Nathan P. Wiederhold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Interplay between Candida albicans and the Antimicrobial Peptide Armory

(2014) Marc Swidergall et al.   EUKARYOTIC CELL

Incidence, characteristics and outcome of ICU-acquired candidemia in India

(2014) Arunaloke Chakrabarti et al.   INTENSIVE CARE MEDICINE

Antifungal Plant Defensins: Mechanisms of Action and Production

(2014) Kim Vriens et al.   MOLECULES

Defensins: antifungal lessons from eukaryotes

(2014) Patrícia M. Silva et al.   Frontiers in Microbiology

Multidrug-resistant endemic clonal strain of Candida auris in India

(2013) A. Chowdhary et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Candida albicans and Non-C. albicans Candida Species: Comparison of Biofilm Production and Metabolic Activity in Biofilms, and Putative Virulence Properties of Isolates from Hospital Environments and Infections

(2013) A. V. Ferreira et al.   MYCOPATHOLOGIA

T-2307 Causes Collapse of Mitochondrial Membrane Potential in Yeast

(2012) Tatsuya Shibata et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fungal hemolysins

(2012) Ajay P. Nayak et al.   MEDICAL MYCOLOGY

Commercialization of antifungal peptides

(2012) Vanessa M.S. Duncan et al.   Fungal Biology Reviews

Use of Antimicrobial Peptides Against Microbial Biofilms: Advantages and Limits

(2011) Giovanna Batoni et al.   CURRENT MEDICINAL CHEMISTRY

First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris

(2011) Wee Gyo Lee et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Uptake of T-2307, a novel arylamidine, in Candida albicans

(2010) H. Nishikawa et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Octenidine Dihydrochloride, a Modern Antiseptic for Skin, Mucous Membranes and Wounds

(2010) N.-O. Hübner et al.   SKIN PHARMACOLOGY AND PHYSIOLOGY

Candida haemuloniiand Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features

(2009) Mi‐Na Kim et al.   CLINICAL INFECTIOUS DISEASES

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital

(2009) Kazuo Satoh et al.   MICROBIOLOGY AND IMMUNOLOGY

In Vitro and In Vivo Antifungal Activities of T-2307, a Novel Arylamidine

(2008) J. Mitsuyama et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candida albicans Cell Wall Proteins

(2008) W. L. Chaffin   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS